FDA Announces 7 More Recalls Of Extended Release Metformin Over NDMA Contamination

(July 14, 2020, 2:53 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on July 13 announced seven additional voluntary recalls of extended-release metformin made by six drug companies due to the possibility that they contain N-nitrosodimethylamine (NDMA) above the acceptable limit....

Related Sections